1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Market Introduction
2. Executive Summary
2.1. Market Snapshot: Global Controlled Substance Market
2.1.1. Global Controlled Substance Market, By Scheduling or Classification
2.1.2. Global Controlled Substance Market, By Therapeutic Use
2.1.3. Global Controlled Substance Market, By Distribution Channel
2.1.4. Global Controlled Substance Market, By Patient Demographics
2.1.5. Global Controlled Substance Market, By Indication
2.1.6. Global Controlled Substance Market, By Region
2.2. Insights from Primary Respondents
3. Market Dynamics & Factors Analysis
3.1. Introduction
3.1.1. Global Controlled Substance Market Value, 2017-2030, (US$ Mn)
3.1.2. Y-o-Y Growth Trend Analysis
3.2. Market Dynamics
3.2.1. Controlled Substance Market Drivers
3.2.2. Controlled Substance Market Restraints
3.2.3. Controlled Substance Market Opportunities
3.2.4. Major Controlled Substance Industry Challenges
3.3. Growth and Development Patterns
3.4. Investment Feasibility Analysis
3.5. Market Opportunity Analysis
3.5.1. Scheduling or Classification
3.5.2. Therapeutic Use
3.5.3. Distribution Channel
3.5.4. Patient Demographics
3.5.5. Indication
3.5.6. Geography
4. Market Competitive Landscape Analysis
4.1. Company Market Share Analysis, 2022
4.1.1. Global Controlled Substance Market: Company Market Share, Value 2022
4.1.2. Global Controlled Substance Market: Top 6 Company Market Share, Value 2022
4.1.3. Global Controlled Substance Market: Top 3 Company Market Share, Value 2022
4.2. Global Controlled Substance Market: Company Revenue Share Analysis, 2022
4.3. Company Assessment Metrics, 2022
4.3.1. Stars
4.3.2. Emerging Leaders
4.3.3. Pervasive Players
4.3.4. Participants
4.4. Startups/SMEs Assessment Metrics, 2022
4.4.1. Progressive Companies
4.4.2. Responsive Companies
4.4.3. Dynamic Companies
4.4.4. Starting Blocks
4.5. Strategic Development
4.5.1. Acquisition and Mergers
4.5.2. New Product Launch
4.5.3. Regional Expansion
4.5.4. Partnerships
4.6. Key Player Product Matrix
4.7. Potential for New Players in the Global Controlled Substance Market
5. Premium Insights
5.1. STAR (Situation, Task, Action, Results) Analysis
5.2. Porter’s Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Bargaining Power of Buyers/Consumers
5.2.3. Bargaining Power of Suppliers
5.2.4. Threat of Substitute Types
5.2.5. Intensity of Competitive Rivalry
5.3. PESTEL Analysis
5.3.1. Political Factors
5.3.2. Economic Factors
5.3.3. Social Factors
5.3.4. Technological Factors
5.3.5. Environmental Factors
5.3.6. Legal Factors
5.4. Key Market Trends
5.4.1. Demand Side Trends
5.4.2. Supply Side Trends
5.5. Value Chain Analysis
5.6. Technology Analysis
5.6.1. Research and development in the global market
5.6.2. Patent Analysis
5.6.3. Emerging technologies and their potential disruption to the market
5.7. Consumer Behaviour Analysis
5.7.1. Consumer Preferences and Expectations
5.7.2. Factors Influencing Consumer Buying Decisions
5.7.2.1. North America
5.7.2.2. Europe
5.7.2.3. Asia Pacific
5.7.2.4. Latin America
5.7.2.5. Middle East and Africa
5.7.3. Consumer Pain Points
5.8. Analysis and Recommendations
5.9. Adjacent Market Analysis
6. Market Positioning of Key Players, 2022
6.1. Company market share of key players, 2022
6.2. Competitive Benchmarking
6.3. Market Positioning of Key Vendors
6.4. Geographical Presence Analysis
6.5. Major Strategies Adopted by Key Players
6.5.1. Key Strategies Analysis
6.5.2. Mergers and Acquisitions
6.5.3. Partnerships
6.5.4. Product Launch
6.5.5. Geographical Expansion
6.5.6. Others
7. Impact Analysis of COVID-19 and Russia – Ukraine War on Controlled Substance Market
7.1. Ukraine-Russia War Impact
7.1.1. Uncertainty and Economic Instability
7.1.2. Supply chain disruptions
7.1.3. Regional market shifts
7.1.4. Shift in government priorities
7.2. COVID-19 Impact Analysis
7.2.1. Supply Chain Disruptions
7.2.2. Demand Fluctuations
7.2.3. Shift in Product Mix
7.2.4. Reduced Industrial Activity
7.2.5. Regional Impact Analysis
7.2.5.1. North America
7.2.5.2. Europe
7.2.5.3. Asia Pacific
7.2.5.4. Latin America
7.2.5.5. Middle East and Africa
8. Global Controlled Substance Market, By Scheduling or Classification
8.1. Global Controlled Substance Market Overview, by Scheduling or Classification
8.1.1. Global Controlled Substance Market Revenue Share, By Scheduling or Classification, 2022 Vs 2030 (in %)
8.2. Schedule I Controlled Substances
8.2.1. Global Controlled Substance Market, By Schedule I Controlled Substances, By Region, 2017-2030 (US$ Mn)
8.2.2. Market Dynamics for Schedule I Controlled Substances
8.2.2.1. Drivers
8.2.2.2. Restraints
8.2.2.3. Opportunities
8.2.2.4. Trends
8.3. Schedule II Controlled Substances
8.3.1. Global Controlled Substance Market, By Schedule II Controlled Substances, By Region, 2017-2030 (US$ Mn)
8.3.2. Market Dynamics for Schedule II Controlled Substances
8.3.2.1. Drivers
8.3.2.2. Restraints
8.3.2.3. Opportunities
8.3.2.4. Trends
8.4. Schedule III Controlled Substances
8.4.1. Global Controlled Substance Market, By Schedule III Controlled Substances, By Region, 2017-2030 (US$ Mn)
8.4.2. Market Dynamics for Schedule III Controlled Substances
8.4.2.1. Drivers
8.4.2.2. Restraints
8.4.2.3. Opportunities
8.4.2.4. Trends
8.5. Schedule IV Controlled Substances
8.5.1. Global Controlled Substance Market, By Schedule IV Controlled Substances, By Region, 2017-2030 (US$ Mn)
8.5.2. Market Dynamics for Schedule IV Controlled Substances
8.5.2.1. Drivers
8.5.2.2. Restraints
8.5.2.3. Opportunities
8.5.2.4. Trends
8.6. Schedule V Controlled Substances
8.6.1. Global Controlled Substance Market, By Schedule V Controlled Substances, By Region, 2017-2030 (US$ Mn)
8.6.2. Market Dynamics for Schedule V Controlled Substances
8.6.2.1. Drivers
8.6.2.2. Restraints
8.6.2.3. Opportunities
8.6.2.4. Trends
8.7. Unscheduled Substances
8.7.1. Global Controlled Substance Market, By Unscheduled Substances, By Region, 2017-2030 (US$ Mn)
8.7.2. Market Dynamics for Unscheduled Substances
8.7.2.1. Drivers
8.7.2.2. Restraints
8.7.2.3. Opportunities
8.7.2.4. Trends
9. Global Controlled Substance Market, By Therapeutic Use
9.1. Global Controlled Substance Market Overview, by Therapeutic Use
9.1.1. Global Controlled Substance Market Revenue Share, By Therapeutic Use, 2022 Vs 2030 (in %)
9.2. Pain Management
9.2.1. Global Controlled Substance Market, By Pain Management, By Region, 2017-2030 (US$ Mn)
9.2.2. Market Dynamics for Pain Management
9.2.2.1. Drivers
9.2.2.2. Restraints
9.2.2.3. Opportunities
9.2.2.4. Trends
9.3. Psychiatric Medications
9.3.1. Global Controlled Substance Market, By Psychiatric Medications, By Region, 2017-2030 (US$ Mn)
9.3.2. Market Dynamics for Psychiatric Medications
9.3.2.1. Drivers
9.3.2.2. Restraints
9.3.2.3. Opportunities
9.3.2.4. Trends
9.4. Substance Abuse Treatment
9.4.1. Global Controlled Substance Market, By Substance Abuse Treatment, By Region, 2017-2030 (US$ Mn)
9.4.2. Market Dynamics for Substance Abuse Treatment
9.4.2.1. Drivers
9.4.2.2. Restraints
9.4.2.3. Opportunities
9.4.2.4. Trends
9.5. Anesthesia
9.5.1. Global Controlled Substance Market, By Anesthesia, By Region, 2017-2030 (US$ Mn)
9.5.2. Market Dynamics for Anesthesia
9.5.2.1. Drivers
9.5.2.2. Restraints
9.5.2.3. Opportunities
9.5.2.4. Trends
9.6. Other Therapeutic Uses
9.6.1. Global Controlled Substance Market, By Other Therapeutic Uses, By Region, 2017-2030 (US$ Mn)
9.6.2. Market Dynamics for Other Therapeutic Uses
9.6.2.1. Drivers
9.6.2.2. Restraints
9.6.2.3. Opportunities
9.6.2.4. Trends
10. Global Controlled Substance Market, By Distribution Channel
10.1. Global Controlled Substance Market Overview, by Distribution Channel
10.1.1. Global Controlled Substance Market Revenue Share, By Distribution Channel, 2022 Vs 2030 (in %)
10.2. Retail Pharmacies
10.2.1. Global Controlled Substance Market, By Retail Pharmacies, By Region, 2017-2030 (US$ Mn)
10.2.2. Market Dynamics for Retail Pharmacies
10.2.2.1. Drivers
10.2.2.2. Restraints
10.2.2.3. Opportunities
10.2.2.4. Trends
10.3. Hospital Pharmacies
10.3.1. Global Controlled Substance Market, By Hospital Pharmacies, By Region, 2017-2030 (US$ Mn)
10.3.2. Market Dynamics for Hospital Pharmacies
10.3.2.1. Drivers
10.3.2.2. Restraints
10.3.2.3. Opportunities
10.3.2.4. Trends
10.4. Specialty Clinics
10.4.1. Global Controlled Substance Market, By Specialty Clinics, By Region, 2017-2030 (US$ Mn)
10.4.2. Market Dynamics for Specialty Clinics
10.4.2.1. Drivers
10.4.2.2. Restraints
10.4.2.3. Opportunities
10.4.2.4. Trends
10.5. Online Pharmacies
10.5.1. Global Controlled Substance Market, By Online Pharmacies, By Region, 2017-2030 (US$ Mn)
10.5.2. Market Dynamics for Online Pharmacies
10.5.2.1. Drivers
10.5.2.2. Restraints
10.5.2.3. Opportunities
10.5.2.4. Trends
11. Global Controlled Substance Market, By Patient Demographics
11.1. Global Controlled Substance Market Overview, by Patient Demographics
11.1.1. Global Controlled Substance Market Revenue Share, By Patient Demographics, 2022 Vs 2030 (in %)
11.2. Adults
11.2.1. Global Controlled Substance Market, By Adults, By Region, 2017-2030 (US$ Mn)
11.2.2. Market Dynamics for Adults
11.2.2.1. Drivers
11.2.2.2. Restraints
11.2.2.3. Opportunities
11.2.2.4. Trends
11.3. Pediatric
11.3.1. Global Controlled Substance Market, By Pediatric, By Region, 2017-2030 (US$ Mn)
11.3.2. Market Dynamics for Pediatric
11.3.2.1. Drivers
11.3.2.2. Restraints
11.3.2.3. Opportunities
11.3.2.4. Trends
12. Global Controlled Substance Market, By Indication
12.1. Global Controlled Substance Market Overview, by Indication
12.1.1. Global Controlled Substance Market Revenue Share, By Indication, 2022 Vs 2030 (in %)
12.2. Chronic Pain
12.2.1. Global Controlled Substance Market, By Chronic Pain, By Region, 2017-2030 (US$ Mn)
12.2.2. Market Dynamics for Chronic Pain
12.2.2.1. Drivers
12.2.2.2. Restraints
12.2.2.3. Opportunities
12.2.2.4. Trends
12.3. Acute Pain
12.3.1. Global Controlled Substance Market, By Acute Pain, By Region, 2017-2030 (US$ Mn)
12.3.2. Market Dynamics for Acute Pain
12.3.2.1. Drivers
12.3.2.2. Restraints
12.3.2.3. Opportunities
12.3.2.4. Trends
12.4. Substance Use Disorder
12.4.1. Global Controlled Substance Market, By Substance Use Disorder, By Region, 2017-2030 (US$ Mn)
12.4.2. Market Dynamics for Substance Use Disorder
12.4.2.1. Drivers
12.4.2.2. Restraints
12.4.2.3. Opportunities
12.4.2.4. Trends
12.5. Mental Health Disorders
12.5.1. Global Controlled Substance Market, By Mental Health Disorders, By Region, 2017-2030 (US$ Mn)
12.5.2. Market Dynamics for Mental Health Disorders
12.5.2.1. Drivers
12.5.2.2. Restraints
12.5.2.3. Opportunities
12.5.2.4. Trends
13. Global Controlled Substance Market, By Region
13.1. Global Controlled Substance Market Overview, by Region
13.1.1. Global Controlled Substance Market, By Region, 2022 vs 2030 (in%)
13.2. Scheduling or Classification
13.2.1. Global Controlled Substance Market, By Scheduling or Classification, 2017-2030 (US$ Mn)
13.3. Therapeutic Use
13.3.1. Global Controlled Substance Market, By Therapeutic Use, 2017-2030 (US$ Mn)
13.4. Distribution Channel
13.4.1. Global Controlled Substance Market, By Distribution Channel, 2017-2030 (US$ Mn)
13.5. Patient Demographics
13.5.1. Global Controlled Substance Market, By Patient Demographics, 2017-2030 (US$ Mn)
13.6. Indication
13.6.1. Global Controlled Substance Market, By Indication, 2017-2030 (US$ Mn)
14. North America Controlled Substance Market Analysis
14.1. Overview
14.1.1. Market Dynamics for North America
14.1.1.1. Drivers
14.1.1.2. Restraints
14.1.1.3. Opportunities
14.1.1.4. Trends
14.2. North America Controlled Substance Market, by Scheduling or Classification, 2017-2030(US$ Mn)
14.2.1. Overview
14.2.2. SRC Analysis
14.3. North America Controlled Substance Market, by Therapeutic Use, 2017-2030(US$ Mn)
14.3.1. Overview
14.3.2. SRC Analysis
14.4. North America Controlled Substance Market, by Distribution Channel, 2017-2030(US$ Mn)
14.4.1. Overview
14.4.2. SRC Analysis
14.5. North America Controlled Substance Market, by Patient Demographics, 2017-2030(US$ Mn)
14.5.1. Overview
14.5.2. SRC Analysis
14.6. North America Controlled Substance Market, by Indication, 2017-2030(US$ Mn)
14.6.1. Overview
14.6.2. SRC Analysis
14.7. North America Controlled Substance Market, by Country, 2017-2030 (US$ Mn)
14.7.1. North America Controlled Substance Market, by Country, 2022 Vs 2030 (in%)
14.7.2. U.S.
14.7.3. Canada
14.7.4. Mexico
15. Europe Controlled Substance Market Analysis
15.1. Overview
15.1.1. Market Dynamics for North America
15.1.1.1. Drivers
15.1.1.2. Restraints
15.1.1.3. Opportunities
15.1.1.4. Trends
15.2. Europe Controlled Substance Market, by Scheduling or Classification, 2017-2030(US$ Mn)
15.2.1. Overview
15.2.2. SRC Analysis
15.3. Europe Controlled Substance Market, by Therapeutic Use, 2017-2030(US$ Mn)
15.3.1. Overview
15.3.2. SRC Analysis
15.4. Europe Controlled Substance Market, by Distribution Channel, 2017-2030(US$ Mn)
15.4.1. Overview
15.4.2. SRC Analysis
15.5. Europe Controlled Substance Market, by Patient Demographics, 2017-2030(US$ Mn)
15.5.1. Overview
15.5.2. SRC Analysis
15.6. Europe Controlled Substance Market, by Indication, 2017-2030(US$ Mn)
15.6.1. Overview
15.6.2. SRC Analysis
15.7. Europe Controlled Substance Market, by Country, 2017-2030 (US$ Mn)
15.7.1. Europe Controlled Substance Market, by Country, 2022 Vs 2030 (in%)
15.7.2. UK
15.7.3. France
15.7.4. Germany
15.7.5. Italy
15.7.6. Spain
15.7.7. Benelux
15.7.8. Russia
15.7.9. Rest of Europe
16. Asia Pacific Controlled Substance Market Analysis
16.1. Overview
16.1.1. Market Dynamics for North America
16.1.1.1. Drivers
16.1.1.2. Restraints
16.1.1.3. Opportunities
16.1.1.4. Trends
16.2. Asia Pacific Controlled Substance Market, by Scheduling or Classification, 2017-2030(US$ Mn)
16.2.1. Overview
16.2.2. SRC Analysis
16.3. Asia Pacific Controlled Substance Market, by Therapeutic Use, 2017-2030(US$ Mn)
16.3.1. Overview
16.3.2. SRC Analysis
16.4. Asia Pacific Controlled Substance Market, by Distribution Channel, 2017-2030(US$ Mn)
16.4.1. Overview
16.4.2. SRC Analysis
16.5. Asia Pacific Controlled Substance Market, by Patient Demographics, 2017-2030(US$ Mn)
16.5.1. Overview
16.5.2. SRC Analysis
16.6. Asia Pacific Controlled Substance Market, by Indication, 2017-2030(US$ Mn)
16.6.1. Overview
16.6.2. SRC Analysis
16.7. Asia Pacific Controlled Substance Market, by Country, 2017-2030 (US$ Mn)
16.7.1. Asia Pacific Controlled Substance Market, by Country, 2022 Vs 2030 (in%)
16.7.2. China
16.7.3. Japan
16.7.4. India
16.7.5. South Korea
16.7.6. South East Asia
16.7.7. Rest of Asia Pacific
17. Latin America Controlled Substance Market Analysis
17.1. Overview
17.1.1. Market Dynamics for North America
17.1.1.1. Drivers
17.1.1.2. Restraints
17.1.1.3. Opportunities
17.1.1.4. Trends
17.2. Latin America Controlled Substance Market, by Scheduling or Classification, 2017-2030(US$ Mn)
17.2.1. Overview
17.2.2. SRC Analysis
17.3. Latin America Controlled Substance Market, by Therapeutic Use, 2017-2030(US$ Mn)
17.3.1. Overview
17.3.2. SRC Analysis
17.4. Latin America Controlled Substance Market, by Distribution Channel, 2017-2030(US$ Mn)
17.4.1. Overview
17.4.2. SRC Analysis
17.5. Latin America Controlled Substance Market, by Patient Demographics, 2017-2030(US$ Mn)
17.5.1. Overview
17.5.2. SRC Analysis
17.6. Latin America Controlled Substance Market, by Indication, 2017-2030(US$ Mn)
17.6.1. Overview
17.6.2. SRC Analysis
17.7. Latin America Controlled Substance Market, by Country, 2017-2030 (US$ Mn)
17.7.1. Latin America Controlled Substance Market, by Country, 2022 Vs 2030 (in%)
17.7.2. Brazil
17.7.3. Argentina
17.7.4. Rest of Latin America
18. Middle East Controlled Substance Market Analysis
18.1. Overview
18.1.1. Market Dynamics for North America
18.1.1.1. Drivers
18.1.1.2. Restraints
18.1.1.3. Opportunities
18.1.1.4. Trends
18.2. Middle East Controlled Substance Market, by Scheduling or Classification, 2017-2030(US$ Mn)
18.2.1. Overview
18.2.2. SRC Analysis
18.3. Middle East Controlled Substance Market, by Therapeutic Use, 2017-2030(US$ Mn)
18.3.1. Overview
18.3.2. SRC Analysis
18.4. Middle East Controlled Substance Market, by Distribution Channel, 2017-2030(US$ Mn)
18.4.1. Overview
18.4.2. SRC Analysis
18.5. Middle East Controlled Substance Market, by Patient Demographics, 2017-2030(US$ Mn)
18.5.1. Overview
18.5.2. SRC Analysis
18.6. Middle East Controlled Substance Market, by Indication, 2017-2030(US$ Mn)
18.6.1. Overview
18.6.2. SRC Analysis
18.7. Middle East Controlled Substance Market, by Country, 2017-2030 (US$ Mn)
18.7.1. Middle East Controlled Substance Market, by Country, 2022 Vs 2030 (in%)
18.7.2. UAE
18.7.3. Saudi Arabia
18.7.4. Rest of Middle East
19. Africa Controlled Substance Market Analysis
19.1. Overview
19.1.1. Market Dynamics for North America
19.1.1.1. Drivers
19.1.1.2. Restraints
19.1.1.3. Opportunities
19.1.1.4. Trends
19.2. Africa Controlled Substance Market, by Scheduling or Classification, 2017-2030(US$ Mn)
19.2.1. Overview
19.2.2. SRC Analysis
19.3. Africa Controlled Substance Market, by Therapeutic Use, 2017-2030(US$ Mn)
19.3.1. Overview
19.3.2. SRC Analysis
19.4. Africa Controlled Substance Market, by Distribution Channel, 2017-2030(US$ Mn)
19.4.1. Overview
19.4.2. SRC Analysis
19.5. Africa Controlled Substance Market, by Patient Demographics, 2017-2030(US$ Mn)
19.5.1. Overview
19.5.2. SRC Analysis
19.6. Africa Controlled Substance Market, by Indication, 2017-2030(US$ Mn)
19.6.1. Overview
19.6.2. SRC Analysis
19.7. Africa Controlled Substance Market, by Country, 2017-2030 (US$ Mn)
19.7.1. Middle East Controlled Substance Market, by Country, 2022 Vs 2030 (in%)
19.7.2. South Africa
19.7.3. Egypt
19.7.4. Rest of Africa
20. Company Profiles
20.1. Johnson & Johnson
20.1.1. Company Overview
20.1.2. Products/Services Portfolio
20.1.3. Geographical Presence
20.1.4. SWOT Analysis
20.1.5. Financial Summary
20.1.5.1. Market Revenue and Net Profit (2019-2022)
20.1.5.2. Business Segment Revenue Analysis
20.1.5.3. Geographical Revenue Analysis
20.2. Pfizer
20.3. Sanofi
20.4. Merck & Co.
20.5. Gilead Sciences
20.6. Amgen
20.7. Novartis
20.8. AbbVie
20.9. GlaxoSmithKline
20.10. AstraZeneca
20.11. Bristol-Myers Squibb
20.12. Eli Lilly
20.13. Teva Pharmaceutical
20.14. Bayer
20.15. Novo Nordisk
20.16. Allergan
20.17. Takeda Pharmaceutical
20.18. Boehringer Ingelheim
20.19. Aspen Pharmacare
20.20. Astellas Pharma
20.21. Others
21. Research Methodology
21.1. Research Methodology
21.2. Phase I – Secondary Research
21.3. Phase II – Data Modelling
21.3.1. Company Share Analysis Model
21.3.2. Revenue Based Modelling
21.4. Phase III – Primary Research
21.5. Research Limitations
21.5.1. Assumptions
List of Figures
FIG. 1 Global Controlled Substance Market: Research Methodology
FIG. 2 Market Size Estimation – Top Down & Bottom Up Approach
FIG. 3 Global Controlled Substance Market Segmentation
FIG. 4 Global Controlled Substance Market, by Scheduling or Classification, 2022 (US$ Mn)
FIG. 5 Global Controlled Substance Market, by Therapeutic Use, 2022 (US$ Mn)
FIG. 6 Global Controlled Substance Market, by Distribution Channel, 2022 (US$ Mn)
FIG. 7 Global Controlled Substance Market, by Patient Demographics, 2022 (US$ Mn)
FIG. 8 Global Controlled Substance Market, by Indication, 2022 (US$ Mn)
FIG. 9 Global Controlled Substance Market, by Geography, 2022 (US$ Mn)
FIG. 10 Attractive Investment Proposition, by Scheduling or Classification, 2022
FIG. 11 Attractive Investment Proposition, by Therapeutic Use, 2022
FIG. 12 Attractive Investment Proposition, by Distribution Channel, 2022
FIG. 13 Attractive Investment Proposition, by Patient Demographics, 2022
FIG. 14 Attractive Investment Proposition, by Indication, 2022
FIG. 15 Attractive Investment Proposition, by Geography, 2022
FIG. 16 Global Market Share Analysis of Key Controlled Substance Market Manufacturers, 2022
FIG. 17 Global Market Positioning of Key Controlled Substance Market Manufacturers, 2022
FIG. 18 Global Controlled Substance Market Value Contribution, By Scheduling or Classification, 2022 & 2030 (Value %)
FIG. 19 Global Controlled Substance Market, by Schedule I Controlled Substances, Value, 2017-2030 (US$ Mn)
FIG. 20 Global Controlled Substance Market, by Schedule II Controlled Substances, Value, 2017-2030 (US$ Mn)
FIG. 21 Global Controlled Substance Market, by Schedule III Controlled Substances, Value, 2017-2030 (US$ Mn)
FIG. 22 Global Controlled Substance Market, by Schedule IV Controlled Substances, Value, 2017-2030 (US$ Mn)
FIG. 23 Global Controlled Substance Market, by Schedule V Controlled Substances, Value, 2017-2030 (US$ Mn)
FIG. 24 Global Controlled Substance Market, by Unscheduled Substances, Value, 2017-2030 (US$ Mn)
FIG. 25 Global Controlled Substance Market Value Contribution, By Therapeutic Use, 2022 & 2030 (Value %)
FIG. 26 Global Controlled Substance Market, by Pain Management, Value, 2017-2030 (US$ Mn)
FIG. 27 Global Controlled Substance Market, by Psychiatric Medications, Value, 2017-2030 (US$ Mn)
FIG. 28 Global Controlled Substance Market, by Substance Abuse Treatment, Value, 2017-2030 (US$ Mn)
FIG. 29 Global Controlled Substance Market, by Anesthesia, Value, 2017-2030 (US$ Mn)
FIG. 30 Global Controlled Substance Market, by Other Therapeutic Uses, Value, 2017-2030 (US$ Mn)
FIG. 31 Global Controlled Substance Market Value Contribution, By Distribution Channel, 2022 & 2030 (Value %)
FIG. 32 Global Controlled Substance Market, by Retail Pharmacies, Value, 2017-2030 (US$ Mn)
FIG. 33 Global Controlled Substance Market, by Hospital Pharmacies, Value, 2017-2030 (US$ Mn)
FIG. 34 Global Controlled Substance Market, by Specialty Clinics, Value, 2017-2030 (US$ Mn)
FIG. 35 Global Controlled Substance Market, by Online Pharmacies, Value, 2017-2030 (US$ Mn)
FIG. 36 Global Controlled Substance Market Value Contribution, By Patient Demographics, 2022 & 2030 (Value %)
FIG. 37 Global Controlled Substance Market, by Adults, Value, 2017-2030 (US$ Mn)
FIG. 38 Global Controlled Substance Market, by Pediatric, Value, 2017-2030 (US$ Mn)
FIG. 39 Global Controlled Substance Market Value Contribution, By Indication, 2022 & 2030 (Value %)
FIG. 40 Global Controlled Substance Market, by Chronic Pain, Value, 2017-2030 (US$ Mn)
FIG. 41 Global Controlled Substance Market, by Acute Pain, Value, 2017-2030 (US$ Mn)
FIG. 42 Global Controlled Substance Market, by Substance Use Disorder, Value, 2017-2030 (US$ Mn)
FIG. 43 Global Controlled Substance Market, by Mental Health Disorders, Value, 2017-2030 (US$ Mn)
FIG. 44 North America Controlled Substance Market, 2017-2030 (US$ Mn)
FIG. 45 U.S. Controlled Substance Market, 2017-2030 (US$ Mn)
FIG. 46 Canada Controlled Substance Market, 2017-2030 (US$ Mn)
FIG. 47 Mexico Controlled Substance Market, 2017-2030 (US$ Mn)
FIG. 48 Europe Controlled Substance Market, 2017-2030 (US$ Mn)
FIG. 49 Germany Controlled Substance Market, 2017-2030 (US$ Mn)
FIG. 50 France Controlled Substance Market, 2017-2030 (US$ Mn)
FIG. 51 U.K. Controlled Substance Market, 2017-2030 (US$ Mn)
FIG. 52 Italy Controlled Substance Market, 2017-2030 (US$ Mn)
FIG. 53 Spain Controlled Substance Market, 2017-2030 (US$ Mn)
FIG. 54 Benelux Controlled Substance Market, 2017-2030 (US$ Mn)
FIG. 55 Russia Controlled Substance Market, 2017-2030 (US$ Mn)
FIG. 56 Rest of Europe Controlled Substance Market, 2017-2030 (US$ Mn)
FIG. 57 Asia Pacific Controlled Substance Market, 2017-2030 (US$ Mn)
FIG. 58 China Controlled Substance Market, 2017-2030 (US$ Mn)
FIG. 59 Japan Controlled Substance Market, 2017-2030 (US$ Mn)
FIG. 60 India Controlled Substance Market, 2017-2030 (US$ Mn)
FIG. 61 South Korea Controlled Substance Market, 2017-2030 (US$ Mn)
FIG. 62 South-East Asia Controlled Substance Market, 2017-2030 (US$ Mn)
FIG. 63 Rest of Asia Pacific Controlled Substance Market, 2017-2030 (US$ Mn)
FIG. 64 Latin America Controlled Substance Market, 2017-2030 (US$ Mn)
FIG. 65 Brazil Controlled Substance Market, 2017-2030 (US$ Mn)
FIG. 66 Argentina Controlled Substance Market, 2017-2030 (US$ Mn)
FIG. 67 Rest of Latin America Controlled Substance Market, 2017-2030 (US$ Mn)
FIG. 68 Middle East Controlled Substance Market, 2017-2030 (US$ Mn)
FIG. 69 UAE Controlled Substance Market, 2017-2030 (US$ Mn)
FIG. 70 Saudi Arabia Controlled Substance Market, 2017-2030 (US$ Mn)
FIG. 71 Rest of Middle East Controlled Substance Market, 2017-2030 (US$ Mn)
FIG. 72 Africa Controlled Substance Market, 2017-2030 (US$ Mn)
FIG. 73 South Africa Controlled Substance Market, 2017-2030 (US$ Mn)
FIG. 74 Egypt Controlled Substance Market, 2017-2030 (US$ Mn)
FIG. 75 Rest of Africa Controlled Substance Market, 2017-2030 (US$ Mn)
List of Tables
TABLE 1 Market Snapshot: Global Controlled Substance Market
TABLE 2 Global Controlled Substance Market: Market Drivers Impact Analysis
TABLE 3 Global Controlled Substance Market: Market Restraints Impact Analysis
TABLE 4 Global Controlled Substance Market, by Competitive Benchmarking, 2022
TABLE 5 Global Controlled Substance Market, by Geographical Presence Analysis, 2022
TABLE 6 Global Controlled Substance Market, by Key Strategies Analysis, 2022
TABLE 7 Global Controlled Substance Market, by Schedule I Controlled Substances, By Region, 2017-2022 (US$ Mn)
TABLE 8 Global Controlled Substance Market, by Schedule I Controlled Substances, By Region, 2023-2030 (US$ Mn)
TABLE 9 Global Controlled Substance Market, by Schedule II Controlled Substances, By Region, 2017-2022 (US$ Mn)
TABLE 10 Global Controlled Substance Market, by Schedule II Controlled Substances, By Region, 2023-2030 (US$ Mn)
TABLE 11 Global Controlled Substance Market, by Schedule III Controlled Substances, By Region, 2017-2022 (US$ Mn)
TABLE 12 Global Controlled Substance Market, by Schedule III Controlled Substances, By Region, 2023-2030 (US$ Mn)
TABLE 13 Global Controlled Substance Market, by Schedule IV Controlled Substances, By Region, 2017-2022 (US$ Mn)
TABLE 14 Global Controlled Substance Market, by Schedule IV Controlled Substances, By Region, 2023-2030 (US$ Mn)
TABLE 15 Global Controlled Substance Market, by Schedule V Controlled Substances, By Region, 2017-2022 (US$ Mn)
TABLE 16 Global Controlled Substance Market, by Schedule V Controlled Substances, By Region, 2023-2030 (US$ Mn)
TABLE 17 Global Controlled Substance Market, by Unscheduled Substances, By Region, 2017-2022 (US$ Mn)
TABLE 18 Global Controlled Substance Market, by Unscheduled Substances, By Region, 2023-2030 (US$ Mn)
TABLE 19 Global Controlled Substance Market, by Pain Management, By Region, 2017-2022 (US$ Mn)
TABLE 20 Global Controlled Substance Market, by Pain Management, By Region, 2023-2030 (US$ Mn)
TABLE 21 Global Controlled Substance Market, by Psychiatric Medications, By Region, 2017-2022 (US$ Mn)
TABLE 22 Global Controlled Substance Market, by Psychiatric Medications, By Region, 2023-2030 (US$ Mn)
TABLE 23 Global Controlled Substance Market, by Substance Abuse Treatment, By Region, 2017-2022 (US$ Mn)
TABLE 24 Global Controlled Substance Market, by Substance Abuse Treatment, By Region, 2023-2030 (US$ Mn)
TABLE 25 Global Controlled Substance Market, by Anesthesia, By Region, 2017-2022 (US$ Mn)
TABLE 26 Global Controlled Substance Market, by Anesthesia, By Region, 2023-2030 (US$ Mn)
TABLE 27 Global Controlled Substance Market, by Other Therapeutic Uses, By Region, 2017-2022 (US$ Mn)
TABLE 28 Global Controlled Substance Market, by Other Therapeutic Uses, By Region, 2023-2030 (US$ Mn)
TABLE 29 Global Controlled Substance Market, by Retail Pharmacies, By Region, 2017-2022 (US$ Mn)
TABLE 30 Global Controlled Substance Market, by Retail Pharmacies, By Region, 2023-2030 (US$ Mn)
TABLE 31 Global Controlled Substance Market, by Hospital Pharmacies, By Region, 2017-2022 (US$ Mn)
TABLE 32 Global Controlled Substance Market, by Hospital Pharmacies, By Region, 2023-2030 (US$ Mn)
TABLE 33 Global Controlled Substance Market, by Specialty Clinics, By Region, 2017-2022 (US$ Mn)
TABLE 34 Global Controlled Substance Market, by Specialty Clinics, By Region, 2023-2030 (US$ Mn)
TABLE 35 Global Controlled Substance Market, by Online Pharmacies, By Region, 2017-2022 (US$ Mn)
TABLE 36 Global Controlled Substance Market, by Online Pharmacies, By Region, 2023-2030 (US$ Mn)
TABLE 37 Global Controlled Substance Market, by Adults, By Region, 2017-2022 (US$ Mn)
TABLE 38 Global Controlled Substance Market, by Adults, By Region, 2023-2030 (US$ Mn)
TABLE 39 Global Controlled Substance Market, by Pediatric, By Region, 2017-2022 (US$ Mn)
TABLE 40 Global Controlled Substance Market, by Pediatric, By Region, 2023-2030 (US$ Mn)
TABLE 41 Global Controlled Substance Market, by Chronic Pain, By Region, 2017-2022 (US$ Mn)
TABLE 42 Global Controlled Substance Market, by Chronic Pain, By Region, 2023-2030 (US$ Mn)
TABLE 43 Global Controlled Substance Market, by Acute Pain, By Region, 2017-2022 (US$ Mn)
TABLE 44 Global Controlled Substance Market, by Acute Pain, By Region, 2023-2030 (US$ Mn)
TABLE 45 Global Controlled Substance Market, by Substance Use Disorder, By Region, 2017-2022 (US$ Mn)
TABLE 46 Global Controlled Substance Market, by Substance Use Disorder, By Region, 2023-2030 (US$ Mn)
TABLE 47 Global Controlled Substance Market, by Mental Health Disorders, By Region, 2017-2022 (US$ Mn)
TABLE 48 Global Controlled Substance Market, by Mental Health Disorders, By Region, 2023-2030 (US$ Mn)
TABLE 49 Global Controlled Substance Market, by Scheduling or Classification, 2017-2022 (US$ Mn)
TABLE 50 Global Controlled Substance Market, by Scheduling or Classification, 2023-2030 (US$ Mn)
TABLE 51 Global Controlled Substance Market, by Therapeutic Use, 2017-2022 (US$ Mn)
TABLE 52 Global Controlled Substance Market, by Therapeutic Use, 2023-2030 (US$ Mn)
TABLE 53 Global Controlled Substance Market, by Distribution Channel, 2017-2022 (US$ Mn)
TABLE 54 Global Controlled Substance Market, by Distribution Channel, 2023-2030 (US$ Mn)
TABLE 55 Global Controlled Substance Market, by Patient Demographics, 2017-2022 (US$ Mn)
TABLE 56 Global Controlled Substance Market, by Patient Demographics, 2023-2030 (US$ Mn)
TABLE 57 Global Controlled Substance Market, by Indication, 2017-2022 (US$ Mn)
TABLE 58 Global Controlled Substance Market, by Indication, 2023-2030 (US$ Mn)
TABLE 59 Global Controlled Substance Market, by Region, 2017-2022 (US$ Mn)
TABLE 60 Global Controlled Substance Market, by Region, 2023-2030 (US$ Mn)
TABLE 61 North America Controlled Substance Market, by Scheduling or Classification, 2017-2022 (US$ Mn)
TABLE 62 North America Controlled Substance Market, by Scheduling or Classification, 2023-2030 (US$ Mn)
TABLE 63 North America Controlled Substance Market, by Therapeutic Use, 2017-2022 (US$ Mn)
TABLE 64 North America Controlled Substance Market, by Therapeutic Use, 2023-2030 (US$ Mn)
TABLE 65 North America Controlled Substance Market, by Distribution Channel, 2017-2022 (US$ Mn)
TABLE 66 North America Controlled Substance Market, by Distribution Channel, 2023-2030 (US$ Mn)
TABLE 67 North America Controlled Substance Market, by Patient Demographics, 2017-2022 (US$ Mn)
TABLE 68 North America Controlled Substance Market, by Patient Demographics, 2023-2030 (US$ Mn)
TABLE 69 North America Controlled Substance Market, by Indication, 2017-2022 (US$ Mn)
TABLE 70 North America Controlled Substance Market, by Indication, 2023-2030 (US$ Mn)
TABLE 71 North America Controlled Substance Market, by Country, 2017-2022 (US$ Mn)
TABLE 72 North America Controlled Substance Market, by Country, 2023-2030 (US$ Mn)
TABLE 73 United States Controlled Substance Market, by Scheduling or Classification, 2017-2022 (US$ Mn)
TABLE 74 United States Controlled Substance Market, by Scheduling or Classification, 2023-2030 (US$ Mn)
TABLE 75 United States Controlled Substance Market, by Therapeutic Use, 2017-2022 (US$ Mn)
TABLE 76 United States Controlled Substance Market, by Therapeutic Use, 2023-2030 (US$ Mn)
TABLE 77 United States Controlled Substance Market, by Distribution Channel, 2017-2022 (US$ Mn)
TABLE 78 United States Controlled Substance Market, by Distribution Channel, 2023-2030 (US$ Mn)
TABLE 79 United States Controlled Substance Market, by Patient Demographics, 2017-2022 (US$ Mn)
TABLE 80 United States Controlled Substance Market, by Patient Demographics, 2023-2030 (US$ Mn)
TABLE 81 United States Controlled Substance Market, by Indication, 2017-2022 (US$ Mn)
TABLE 82 United States Controlled Substance Market, by Indication, 2023-2030 (US$ Mn)
TABLE 83 Canada Controlled Substance Market, by Scheduling or Classification, 2017-2022 (US$ Mn)
TABLE 84 Canada Controlled Substance Market, by Scheduling or Classification, 2023-2030 (US$ Mn)
TABLE 85 Canada Controlled Substance Market, by Therapeutic Use, 2017-2022 (US$ Mn)
TABLE 86 Canada Controlled Substance Market, by Therapeutic Use, 2023-2030 (US$ Mn)
TABLE 87 Canada Controlled Substance Market, by Distribution Channel, 2017-2022 (US$ Mn)
TABLE 88 Canada Controlled Substance Market, by Distribution Channel, 2023-2030 (US$ Mn)
TABLE 89 Canada Controlled Substance Market, by Patient Demographics, 2017-2022 (US$ Mn)
TABLE 90 Canada Controlled Substance Market, by Patient Demographics, 2023-2030 (US$ Mn)
TABLE 91 Canada Controlled Substance Market, by Indication, 2017-2022 (US$ Mn)
TABLE 92 Canada Controlled Substance Market, by Indication, 2023-2030 (US$ Mn)
TABLE 93 Mexico Controlled Substance Market, by Scheduling or Classification, 2017-2022 (US$ Mn)
TABLE 94 Mexico Controlled Substance Market, by Scheduling or Classification, 2023-2030 (US$ Mn)
TABLE 95 Mexico Controlled Substance Market, by Therapeutic Use, 2017-2022 (US$ Mn)
TABLE 96 Mexico Controlled Substance Market, by Therapeutic Use, 2023-2030 (US$ Mn)
TABLE 97 Mexico Controlled Substance Market, by Distribution Channel, 2017-2022 (US$ Mn)
TABLE 98 Mexico Controlled Substance Market, by Distribution Channel, 2023-2030 (US$ Mn)
TABLE 99 Mexico Controlled Substance Market, by Patient Demographics, 2017-2022 (US$ Mn)
TABLE 100 Mexico Controlled Substance Market, by Patient Demographics, 2023-2030 (US$ Mn)
TABLE 101 Mexico Controlled Substance Market, by Indication, 2017-2022 (US$ Mn)
TABLE 102 Mexico Controlled Substance Market, by Indication, 2023-2030 (US$ Mn)
TABLE 103 Europe Controlled Substance Market, by Scheduling or Classification, 2017-2022 (US$ Mn)
TABLE 104 Europe Controlled Substance Market, by Scheduling or Classification, 2023-2030 (US$ Mn)
TABLE 105 Europe Controlled Substance Market, by Therapeutic Use, 2017-2022 (US$ Mn)
TABLE 106 Europe Controlled Substance Market, by Therapeutic Use, 2023-2030 (US$ Mn)
TABLE 107 Europe Controlled Substance Market, by Distribution Channel, 2017-2022 (US$ Mn)
TABLE 108 Europe Controlled Substance Market, by Distribution Channel, 2023-2030 (US$ Mn)
TABLE 109 Europe Controlled Substance Market, by Patient Demographics, 2017-2022 (US$ Mn)
TABLE 110 Europe Controlled Substance Market, by Patient Demographics, 2023-2030 (US$ Mn)
TABLE 111 Europe Controlled Substance Market, by Indication, 2017-2022 (US$ Mn)
TABLE 112 Europe Controlled Substance Market, by Indication, 2023-2030 (US$ Mn)
TABLE 113 Europe Controlled Substance Market, by Country, 2017-2022 (US$ Mn)
TABLE 114 Europe Controlled Substance Market, by Country, 2023-2030 (US$ Mn)
TABLE 115 Germany Controlled Substance Market, by Scheduling or Classification, 2017-2022 (US$ Mn)
TABLE 116 Germany Controlled Substance Market, by Scheduling or Classification, 2023-2030 (US$ Mn)
TABLE 117 Germany Controlled Substance Market, by Therapeutic Use, 2017-2022 (US$ Mn)
TABLE 118 Germany Controlled Substance Market, by Therapeutic Use, 2023-2030 (US$ Mn)
TABLE 119 Germany Controlled Substance Market, by Distribution Channel, 2017-2022 (US$ Mn)
TABLE 120 Germany Controlled Substance Market, by Distribution Channel, 2023-2030 (US$ Mn)
TABLE 121 Germany Controlled Substance Market, by Patient Demographics, 2017-2022 (US$ Mn)
TABLE 122 Germany Controlled Substance Market, by Patient Demographics, 2023-2030 (US$ Mn)
TABLE 123 Germany Controlled Substance Market, by Indication, 2017-2022 (US$ Mn)
TABLE 124 Germany Controlled Substance Market, by Indication, 2023-2030 (US$ Mn)
TABLE 125 France Controlled Substance Market, by Scheduling or Classification, 2017-2022 (US$ Mn)
TABLE 126 France Controlled Substance Market, by Scheduling or Classification, 2023-2030 (US$ Mn)
TABLE 127 France Controlled Substance Market, by Therapeutic Use, 2017-2022 (US$ Mn)
TABLE 128 France Controlled Substance Market, by Therapeutic Use, 2023-2030 (US$ Mn)
TABLE 129 France Controlled Substance Market, by Distribution Channel, 2017-2022 (US$ Mn)
TABLE 130 France Controlled Substance Market, by Distribution Channel, 2023-2030 (US$ Mn)
TABLE 131 France Controlled Substance Market, by Patient Demographics, 2017-2022 (US$ Mn)
TABLE 132 France Controlled Substance Market, by Patient Demographics, 2023-2030 (US$ Mn)
TABLE 133 France Controlled Substance Market, by Indication, 2017-2022 (US$ Mn)
TABLE 134 France Controlled Substance Market, by Indication, 2023-2030 (US$ Mn)
TABLE 135 United Kingdom Controlled Substance Market, by Scheduling or Classification, 2017-2022 (US$ Mn)
TABLE 136 United Kingdom Controlled Substance Market, by Scheduling or Classification, 2023-2030 (US$ Mn)
TABLE 137 United Kingdom Controlled Substance Market, by Therapeutic Use, 2017-2022 (US$ Mn)
TABLE 138 United Kingdom Controlled Substance Market, by Therapeutic Use, 2023-2030 (US$ Mn)
TABLE 139 United Kingdom Controlled Substance Market, by Distribution Channel, 2017-2022 (US$ Mn)
TABLE 140 United Kingdom Controlled Substance Market, by Distribution Channel, 2023-2030 (US$ Mn)
TABLE 141 United Kingdom Controlled Substance Market, by Patient Demographics, 2017-2022 (US$ Mn)
TABLE 142 United Kingdom Controlled Substance Market, by Patient Demographics, 2023-2030 (US$ Mn)
TABLE 143 United Kingdom Controlled Substance Market, by Indication, 2017-2022 (US$ Mn)
TABLE 144 United Kingdom Controlled Substance Market, by Indication, 2023-2030 (US$ Mn)
TABLE 145 Italy Controlled Substance Market, by Scheduling or Classification, 2017-2022 (US$ Mn)
TABLE 146 Italy Controlled Substance Market, by Scheduling or Classification, 2023-2030 (US$ Mn)
TABLE 147 Italy Controlled Substance Market, by Therapeutic Use, 2017-2022 (US$ Mn)
TABLE 148 Italy Controlled Substance Market, by Therapeutic Use, 2023-2030 (US$ Mn)
TABLE 149 Italy Controlled Substance Market, by Distribution Channel, 2017-2022 (US$ Mn)
TABLE 150 Italy Controlled Substance Market, by Distribution Channel, 2023-2030 (US$ Mn)
TABLE 151 Italy Controlled Substance Market, by Patient Demographics, 2017-2022 (US$ Mn)
TABLE 152 Italy Controlled Substance Market, by Patient Demographics, 2023-2030 (US$ Mn)
TABLE 153 Italy Controlled Substance Market, by Indication, 2017-2022 (US$ Mn)
TABLE 154 Italy Controlled Substance Market, by Indication, 2023-2030 (US$ Mn)
TABLE 155 Spain Controlled Substance Market, by Scheduling or Classification, 2017-2022 (US$ Mn)
TABLE 156 Spain Controlled Substance Market, by Scheduling or Classification, 2023-2030 (US$ Mn)
TABLE 157 Spain Controlled Substance Market, by Therapeutic Use, 2017-2022 (US$ Mn)
TABLE 158 Spain Controlled Substance Market, by Therapeutic Use, 2023-2030 (US$ Mn)
TABLE 159 Spain Controlled Substance Market, by Distribution Channel, 2017-2022 (US$ Mn)
TABLE 160 Spain Controlled Substance Market, by Distribution Channel, 2023-2030 (US$ Mn)
TABLE 161 Spain Controlled Substance Market, by Patient Demographics, 2017-2022 (US$ Mn)
TABLE 162 Spain Controlled Substance Market, by Patient Demographics, 2023-2030 (US$ Mn)
TABLE 163 Spain Controlled Substance Market, by Indication, 2017-2022 (US$ Mn)
TABLE 164 Spain Controlled Substance Market, by Indication, 2023-2030 (US$ Mn)
TABLE 165 Benelux Controlled Substance Market, by Scheduling or Classification, 2017-2022 (US$ Mn)
TABLE 166 Benelux Controlled Substance Market, by Scheduling or Classification, 2023-2030 (US$ Mn)
TABLE 167 Benelux Controlled Substance Market, by Therapeutic Use, 2017-2022 (US$ Mn)
TABLE 168 Benelux Controlled Substance Market, by Therapeutic Use, 2023-2030 (US$ Mn)
TABLE 169 Benelux Controlled Substance Market, by Distribution Channel, 2017-2022 (US$ Mn)
TABLE 170 Benelux Controlled Substance Market, by Distribution Channel, 2023-2030 (US$ Mn)
TABLE 171 Benelux Controlled Substance Market, by Patient Demographics, 2017-2022 (US$ Mn)
TABLE 172 Benelux Controlled Substance Market, by Patient Demographics, 2023-2030 (US$ Mn)
TABLE 173 Benelux Controlled Substance Market, by Indication, 2017-2022 (US$ Mn)
TABLE 174 Benelux Controlled Substance Market, by Indication, 2023-2030 (US$ Mn)
TABLE 175 Russia Controlled Substance Market, by Scheduling or Classification, 2017-2022 (US$ Mn)
TABLE 176 Russia Controlled Substance Market, by Scheduling or Classification, 2023-2030 (US$ Mn)
TABLE 177 Russia Controlled Substance Market, by Therapeutic Use, 2017-2022 (US$ Mn)
TABLE 178 Russia Controlled Substance Market, by Therapeutic Use, 2023-2030 (US$ Mn)
TABLE 179 Russia Controlled Substance Market, by Distribution Channel, 2017-2022 (US$ Mn)
TABLE 180 Russia Controlled Substance Market, by Distribution Channel, 2023-2030 (US$ Mn)
TABLE 181 Russia Controlled Substance Market, by Patient Demographics, 2017-2022 (US$ Mn)
TABLE 182 Russia Controlled Substance Market, by Patient Demographics, 2023-2030 (US$ Mn)
TABLE 183 Russia Controlled Substance Market, by Indication, 2017-2022 (US$ Mn)
TABLE 184 Russia Controlled Substance Market, by Indication, 2023-2030 (US$ Mn)
TABLE 185 Rest of Europe Controlled Substance Market, by Scheduling or Classification, 2017-2022 (US$ Mn)
TABLE 186 Rest of Europe Controlled Substance Market, by Scheduling or Classification, 2023-2030 (US$ Mn)
TABLE 187 Rest of Europe Controlled Substance Market, by Therapeutic Use, 2017-2022 (US$ Mn)
TABLE 188 Rest of Europe Controlled Substance Market, by Therapeutic Use, 2023-2030 (US$ Mn)
TABLE 189 Rest of Europe Controlled Substance Market, by Distribution Channel, 2017-2022 (US$ Mn)
TABLE 190 Rest of Europe Controlled Substance Market, by Distribution Channel, 2023-2030 (US$ Mn)
TABLE 191 Rest of Europe Controlled Substance Market, by Patient Demographics, 2017-2022 (US$ Mn)
TABLE 192 Rest of Europe Controlled Substance Market, by Patient Demographics, 2023-2030 (US$ Mn)
TABLE 193 Rest of Europe Controlled Substance Market, by Indication, 2017-2022 (US$ Mn)
TABLE 194 Rest of Europe Controlled Substance Market, by Indication, 2023-2030 (US$ Mn)
TABLE 195 Asia Pacific Controlled Substance Market, by Scheduling or Classification, 2017-2022 (US$ Mn)
TABLE 196 Asia Pacific Controlled Substance Market, by Scheduling or Classification, 2023-2030 (US$ Mn)
TABLE 197 Asia Pacific Controlled Substance Market, by Therapeutic Use, 2017-2022 (US$ Mn)
TABLE 198 Asia Pacific Controlled Substance Market, by Therapeutic Use, 2023-2030 (US$ Mn)
TABLE 199 Asia Pacific Controlled Substance Market, by Distribution Channel, 2017-2022 (US$ Mn)
TABLE 200 Asia Pacific Controlled Substance Market, by Distribution Channel, 2023-2030 (US$ Mn)
TABLE 201 Asia Pacific Controlled Substance Market, by Patient Demographics, 2017-2022 (US$ Mn)
TABLE 202 Asia Pacific Controlled Substance Market, by Patient Demographics, 2023-2030 (US$ Mn)
TABLE 203 Asia Pacific Controlled Substance Market, by Indication, 2017-2022 (US$ Mn)
TABLE 204 Asia Pacific Controlled Substance Market, by Indication, 2023-2030 (US$ Mn)
TABLE 205 China Controlled Substance Market, by Scheduling or Classification, 2017-2022 (US$ Mn)
TABLE 206 China Controlled Substance Market, by Scheduling or Classification, 2023-2030 (US$ Mn)
TABLE 207 China Controlled Substance Market, by Therapeutic Use, 2017-2022 (US$ Mn)
TABLE 208 China Controlled Substance Market, by Therapeutic Use, 2023-2030 (US$ Mn)
TABLE 209 China Controlled Substance Market, by Distribution Channel, 2017-2022 (US$ Mn)
TABLE 210 China Controlled Substance Market, by Distribution Channel, 2023-2030 (US$ Mn)
TABLE 211 China Controlled Substance Market, by Patient Demographics, 2017-2022 (US$ Mn)
TABLE 212 China Controlled Substance Market, by Patient Demographics, 2023-2030 (US$ Mn)
TABLE 213 China Controlled Substance Market, by Indication, 2017-2022 (US$ Mn)
TABLE 214 China Controlled Substance Market, by Indication, 2023-2030 (US$ Mn)
TABLE 215 Japan Controlled Substance Market, by Scheduling or Classification, 2017-2022 (US$ Mn)
TABLE 216 Japan Controlled Substance Market, by Scheduling or Classification, 2023-2030 (US$ Mn)
TABLE 217 Japan Controlled Substance Market, by Therapeutic Use, 2017-2022 (US$ Mn)
TABLE 218 Japan Controlled Substance Market, by Therapeutic Use, 2023-2030 (US$ Mn)
TABLE 219 Japan Controlled Substance Market, by Distribution Channel, 2017-2022 (US$ Mn)
TABLE 220 Japan Controlled Substance Market, by Distribution Channel, 2023-2030 (US$ Mn)
TABLE 221 Japan Controlled Substance Market, by Patient Demographics, 2017-2022 (US$ Mn)
TABLE 222 Japan Controlled Substance Market, by Patient Demographics, 2023-2030 (US$ Mn)
TABLE 223 Japan Controlled Substance Market, by Indication, 2017-2022 (US$ Mn)
TABLE 224 Japan Controlled Substance Market, by Indication, 2023-2030 (US$ Mn)
TABLE 225 India Controlled Substance Market, by Scheduling or Classification, 2017-2022 (US$ Mn)
TABLE 226 India Controlled Substance Market, by Scheduling or Classification, 2023-2030 (US$ Mn)
TABLE 227 India Controlled Substance Market, by Therapeutic Use, 2017-2022 (US$ Mn)
TABLE 228 India Controlled Substance Market, by Therapeutic Use, 2023-2030 (US$ Mn)
TABLE 229 India Controlled Substance Market, by Distribution Channel, 2017-2022 (US$ Mn)
TABLE 230 India Controlled Substance Market, by Distribution Channel, 2023-2030 (US$ Mn)
TABLE 231 India Controlled Substance Market, by Patient Demographics, 2017-2022 (US$ Mn)
TABLE 232 India Controlled Substance Market, by Patient Demographics, 2023-2030 (US$ Mn)
TABLE 233 India Controlled Substance Market, by Indication, 2017-2022 (US$ Mn)
TABLE 234 India Controlled Substance Market, by Indication, 2023-2030 (US$ Mn)
TABLE 235 South Korea Controlled Substance Market, by Scheduling or Classification, 2017-2022 (US$ Mn)
TABLE 236 South Korea Controlled Substance Market, by Scheduling or Classification, 2023-2030 (US$ Mn)
TABLE 237 South Korea Controlled Substance Market, by Therapeutic Use, 2017-2022 (US$ Mn)
TABLE 238 South Korea Controlled Substance Market, by Therapeutic Use, 2023-2030 (US$ Mn)
TABLE 239 South Korea Controlled Substance Market, by Distribution Channel, 2017-2022 (US$ Mn)
TABLE 240 South Korea Controlled Substance Market, by Distribution Channel, 2023-2030 (US$ Mn)
TABLE 241 South Korea Controlled Substance Market, by Patient Demographics, 2017-2022 (US$ Mn)
TABLE 242 South Korea Controlled Substance Market, by Patient Demographics, 2023-2030 (US$ Mn)
TABLE 243 South Korea Controlled Substance Market, by Indication, 2017-2022 (US$ Mn)
TABLE 244 South Korea Controlled Substance Market, by Indication, 2023-2030 (US$ Mn)
TABLE 245 South-East Asia Controlled Substance Market, by Scheduling or Classification, 2017-2022 (US$ Mn)
TABLE 246 South-East Asia Controlled Substance Market, by Scheduling or Classification, 2023-2030 (US$ Mn)
TABLE 247 South-East Asia Controlled Substance Market, by Therapeutic Use, 2017-2022 (US$ Mn)
TABLE 248 South-East Asia Controlled Substance Market, by Therapeutic Use, 2023-2030 (US$ Mn)
TABLE 249 South-East Asia Controlled Substance Market, by Distribution Channel, 2017-2022 (US$ Mn)
TABLE 250 South-East Asia Controlled Substance Market, by Distribution Channel, 2023-2030 (US$ Mn)
TABLE 251 South-East Asia Controlled Substance Market, by Patient Demographics, 2017-2022 (US$ Mn)
TABLE 252 South-East Asia Controlled Substance Market, by Patient Demographics, 2023-2030 (US$ Mn)
TABLE 253 South-East Asia Controlled Substance Market, by Indication, 2017-2022 (US$ Mn)
TABLE 254 South-East Asia Controlled Substance Market, by Indication, 2023-2030 (US$ Mn)
TABLE 255 Rest of Asia Pacific Controlled Substance Market, by Scheduling or Classification, 2017-2022 (US$ Mn)
TABLE 256 Rest of Asia Pacific Controlled Substance Market, by Scheduling or Classification, 2023-2030 (US$ Mn)
TABLE 257 Rest of Asia Pacific Controlled Substance Market, by Therapeutic Use, 2017-2022 (US$ Mn)
TABLE 258 Rest of Asia Pacific Controlled Substance Market, by Therapeutic Use, 2023-2030 (US$ Mn)
TABLE 259 Rest of Asia Pacific Controlled Substance Market, by Distribution Channel, 2017-2022 (US$ Mn)
TABLE 260 Rest of Asia Pacific Controlled Substance Market, by Distribution Channel, 2023-2030 (US$ Mn)
TABLE 261 Rest of Asia Pacific Controlled Substance Market, by Patient Demographics, 2017-2022 (US$ Mn)
TABLE 262 Rest of Asia Pacific Controlled Substance Market, by Patient Demographics, 2023-2030 (US$ Mn)
TABLE 263 Rest of Asia Pacific Controlled Substance Market, by Indication, 2017-2022 (US$ Mn)
TABLE 264 Rest of Asia Pacific Controlled Substance Market, by Indication, 2023-2030 (US$ Mn)
TABLE 265 Latin America Controlled Substance Market, by Scheduling or Classification, 2017-2022 (US$ Mn)
TABLE 266 Latin America Controlled Substance Market, by Scheduling or Classification, 2023-2030 (US$ Mn)
TABLE 267 Latin America Controlled Substance Market, by Therapeutic Use, 2017-2022 (US$ Mn)
TABLE 268 Latin America Controlled Substance Market, by Therapeutic Use, 2023-2030 (US$ Mn)
TABLE 269 Latin America Controlled Substance Market, by Distribution Channel, 2017-2022 (US$ Mn)
TABLE 270 Latin America Controlled Substance Market, by Distribution Channel, 2023-2030 (US$ Mn)
TABLE 271 Latin America Controlled Substance Market, by Patient Demographics, 2017-2022 (US$ Mn)
TABLE 272 Latin America Controlled Substance Market, by Patient Demographics, 2023-2030 (US$ Mn)
TABLE 273 Latin America Controlled Substance Market, by Indication, 2017-2022 (US$ Mn)
TABLE 274 Latin America Controlled Substance Market, by Indication, 2023-2030 (US$ Mn)
TABLE 275 Brazil Controlled Substance Market, by Scheduling or Classification, 2017-2022 (US$ Mn)
TABLE 276 Brazil Controlled Substance Market, by Scheduling or Classification, 2023-2030 (US$ Mn)
TABLE 277 Brazil Controlled Substance Market, by Therapeutic Use, 2017-2022 (US$ Mn)
TABLE 278 Brazil Controlled Substance Market, by Therapeutic Use, 2023-2030 (US$ Mn)
TABLE 279 Brazil Controlled Substance Market, by Distribution Channel, 2017-2022 (US$ Mn)
TABLE 280 Brazil Controlled Substance Market, by Distribution Channel, 2023-2030 (US$ Mn)
TABLE 281 Brazil Controlled Substance Market, by Patient Demographics, 2017-2022 (US$ Mn)
TABLE 282 Brazil Controlled Substance Market, by Patient Demographics, 2023-2030 (US$ Mn)
TABLE 283 Brazil Controlled Substance Market, by Indication, 2017-2022 (US$ Mn)
TABLE 284 Brazil Controlled Substance Market, by Indication, 2023-2030 (US$ Mn)
TABLE 285 Argentina Controlled Substance Market, by Scheduling or Classification, 2017-2022 (US$ Mn)
TABLE 286 Argentina Controlled Substance Market, by Scheduling or Classification, 2023-2030 (US$ Mn)
TABLE 287 Argentina Controlled Substance Market, by Therapeutic Use, 2017-2022 (US$ Mn)
TABLE 288 Argentina Controlled Substance Market, by Therapeutic Use, 2023-2030 (US$ Mn)
TABLE 289 Argentina Controlled Substance Market, by Distribution Channel, 2017-2022 (US$ Mn)
TABLE 290 Argentina Controlled Substance Market, by Distribution Channel, 2023-2030 (US$ Mn)
TABLE 291 Argentina Controlled Substance Market, by Patient Demographics, 2017-2022 (US$ Mn)
TABLE 292 Argentina Controlled Substance Market, by Patient Demographics, 2023-2030 (US$ Mn)
TABLE 293 Argentina Controlled Substance Market, by Indication, 2017-2022 (US$ Mn)
TABLE 294 Argentina Controlled Substance Market, by Indication, 2023-2030 (US$ Mn)
TABLE 295 Rest of Latin America Controlled Substance Market, by Scheduling or Classification, 2017-2022 (US$ Mn)
TABLE 296 Rest of Latin America Controlled Substance Market, by Scheduling or Classification, 2023-2030 (US$ Mn)
TABLE 297 Rest of Latin America Controlled Substance Market, by Therapeutic Use, 2017-2022 (US$ Mn)
TABLE 298 Rest of Latin America Controlled Substance Market, by Therapeutic Use, 2023-2030 (US$ Mn)
TABLE 299 Rest of Latin America Controlled Substance Market, by Distribution Channel, 2017-2022 (US$ Mn)
TABLE 300 Rest of Latin America Controlled Substance Market, by Distribution Channel, 2023-2030 (US$ Mn)
TABLE 301 Rest of Latin America Controlled Substance Market, by Patient Demographics, 2017-2022 (US$ Mn)
TABLE 302 Rest of Latin America Controlled Substance Market, by Patient Demographics, 2023-2030 (US$ Mn)
TABLE 303 Rest of Latin America Controlled Substance Market, by Indication, 2017-2022 (US$ Mn)
TABLE 304 Rest of Latin America Controlled Substance Market, by Indication, 2023-2030 (US$ Mn)
TABLE 305 Middle East Controlled Substance Market, by Scheduling or Classification, 2017-2022 (US$ Mn)
TABLE 306 Middle East Controlled Substance Market, by Scheduling or Classification, 2023-2030 (US$ Mn)
TABLE 307 Middle East Controlled Substance Market, by Therapeutic Use, 2017-2022 (US$ Mn)
TABLE 308 Middle East Controlled Substance Market, by Therapeutic Use, 2023-2030 (US$ Mn)
TABLE 309 Middle East Controlled Substance Market, by Distribution Channel, 2017-2022 (US$ Mn)
TABLE 310 Middle East Controlled Substance Market, by Distribution Channel, 2023-2030 (US$ Mn)
TABLE 311 Middle East Controlled Substance Market, by Patient Demographics, 2017-2022 (US$ Mn)
TABLE 312 Middle East Controlled Substance Market, by Patient Demographics, 2023-2030 (US$ Mn)
TABLE 313 Middle East Controlled Substance Market, by Indication, 2017-2022 (US$ Mn)
TABLE 314 Middle East Controlled Substance Market, by Indication, 2023-2030 (US$ Mn)
TABLE 315 UAE Controlled Substance Market, by Scheduling or Classification, 2017-2022 (US$ Mn)
TABLE 316 UAE Controlled Substance Market, by Scheduling or Classification, 2023-2030 (US$ Mn)
TABLE 317 UAE Controlled Substance Market, by Therapeutic Use, 2017-2022 (US$ Mn)
TABLE 318 UAE Controlled Substance Market, by Therapeutic Use, 2023-2030 (US$ Mn)
TABLE 319 UAE Controlled Substance Market, by Distribution Channel, 2017-2022 (US$ Mn)
TABLE 320 UAE Controlled Substance Market, by Distribution Channel, 2023-2030 (US$ Mn)
TABLE 321 UAE Controlled Substance Market, by Patient Demographics, 2017-2022 (US$ Mn)
TABLE 322 UAE Controlled Substance Market, by Patient Demographics, 2023-2030 (US$ Mn)
TABLE 323 UAE Controlled Substance Market, by Indication, 2017-2022 (US$ Mn)
TABLE 324 UAE Controlled Substance Market, by Indication, 2023-2030 (US$ Mn)
TABLE 325 Saudi Arabia Controlled Substance Market, by Scheduling or Classification, 2017-2022 (US$ Mn)
TABLE 326 Saudi Arabia Controlled Substance Market, by Scheduling or Classification, 2023-2030 (US$ Mn)
TABLE 327 Saudi Arabia Controlled Substance Market, by Therapeutic Use, 2017-2022 (US$ Mn)
TABLE 328 Saudi Arabia Controlled Substance Market, by Therapeutic Use, 2023-2030 (US$ Mn)
TABLE 329 Saudi Arabia Controlled Substance Market, by Distribution Channel, 2017-2022 (US$ Mn)
TABLE 330 Saudi Arabia Controlled Substance Market, by Distribution Channel, 2023-2030 (US$ Mn)
TABLE 331 Saudi Arabia Controlled Substance Market, by Patient Demographics, 2017-2022 (US$ Mn)
TABLE 332 Saudi Arabia Controlled Substance Market, by Patient Demographics, 2023-2030 (US$ Mn)
TABLE 333 Saudi Arabia Controlled Substance Market, by Indication, 2017-2022 (US$ Mn)
TABLE 334 Saudi Arabia Controlled Substance Market, by Indication, 2023-2030 (US$ Mn)
TABLE 335 Rest of Middle East Controlled Substance Market, by Scheduling or Classification, 2017-2022 (US$ Mn)
TABLE 336 Rest of Middle East Controlled Substance Market, by Scheduling or Classification, 2023-2030 (US$ Mn)
TABLE 337 Rest of Middle East Controlled Substance Market, by Therapeutic Use, 2017-2022 (US$ Mn)
TABLE 338 Rest of Middle East Controlled Substance Market, by Therapeutic Use, 2023-2030 (US$ Mn)
TABLE 339 Rest of Middle East Controlled Substance Market, by Distribution Channel, 2017-2022 (US$ Mn)
TABLE 340 Rest of Middle East Controlled Substance Market, by Distribution Channel, 2023-2030 (US$ Mn)
TABLE 341 Rest of Middle East Controlled Substance Market, by Patient Demographics, 2017-2022 (US$ Mn)
TABLE 342 Rest of Middle East Controlled Substance Market, by Patient Demographics, 2023-2030 (US$ Mn)
TABLE 343 Rest of Middle East Controlled Substance Market, by Indication, 2017-2022 (US$ Mn)
TABLE 344 Rest of Middle East Controlled Substance Market, by Indication, 2023-2030 (US$ Mn)
TABLE 345 Africa Controlled Substance Market, by Scheduling or Classification, 2017-2022 (US$ Mn)
TABLE 346 Africa Controlled Substance Market, by Scheduling or Classification, 2023-2030 (US$ Mn)
TABLE 347 Africa Controlled Substance Market, by Therapeutic Use, 2017-2022 (US$ Mn)
TABLE 348 Africa Controlled Substance Market, by Therapeutic Use, 2023-2030 (US$ Mn)
TABLE 349 Africa Controlled Substance Market, by Distribution Channel, 2017-2022 (US$ Mn)
TABLE 350 Africa Controlled Substance Market, by Distribution Channel, 2023-2030 (US$ Mn)
TABLE 351 Africa Controlled Substance Market, by Patient Demographics, 2017-2022 (US$ Mn)
TABLE 352 Africa Controlled Substance Market, by Patient Demographics, 2023-2030 (US$ Mn)
TABLE 353 Africa Controlled Substance Market, by Indication, 2017-2022 (US$ Mn)
TABLE 354 Africa Controlled Substance Market, by Indication, 2023-2030 (US$ Mn)
TABLE 355 South Africa Controlled Substance Market, by Scheduling or Classification, 2017-2022 (US$ Mn)
TABLE 356 South Africa Controlled Substance Market, by Scheduling or Classification, 2023-2030 (US$ Mn)
TABLE 357 South Africa Controlled Substance Market, by Therapeutic Use, 2017-2022 (US$ Mn)
TABLE 358 South Africa Controlled Substance Market, by Therapeutic Use, 2023-2030 (US$ Mn)
TABLE 359 South Africa Controlled Substance Market, by Distribution Channel, 2017-2022 (US$ Mn)
TABLE 360 South Africa Controlled Substance Market, by Distribution Channel, 2023-2030 (US$ Mn)
TABLE 361 South Africa Controlled Substance Market, by Patient Demographics, 2017-2022 (US$ Mn)
TABLE 362 South Africa Controlled Substance Market, by Patient Demographics, 2023-2030 (US$ Mn)
TABLE 363 South Africa Controlled Substance Market, by Indication, 2017-2022 (US$ Mn)
TABLE 364 South Africa Controlled Substance Market, by Indication, 2023-2030 (US$ Mn)
TABLE 365 Egypt Controlled Substance Market, by Scheduling or Classification, 2017-2022 (US$ Mn)
TABLE 366 Egypt Controlled Substance Market, by Scheduling or Classification, 2023-2030 (US$ Mn)
TABLE 367 Egypt Controlled Substance Market, by Therapeutic Use, 2017-2022 (US$ Mn)
TABLE 368 Egypt Controlled Substance Market, by Therapeutic Use, 2023-2030 (US$ Mn)
TABLE 369 Egypt Controlled Substance Market, by Distribution Channel, 2017-2022 (US$ Mn)
TABLE 370 Egypt Controlled Substance Market, by Distribution Channel, 2023-2030 (US$ Mn)
TABLE 371 Egypt Controlled Substance Market, by Patient Demographics, 2017-2022 (US$ Mn)
TABLE 372 Egypt Controlled Substance Market, by Patient Demographics, 2023-2030 (US$ Mn)
TABLE 373 Egypt Controlled Substance Market, by Indication, 2017-2022 (US$ Mn)
TABLE 374 Egypt Controlled Substance Market, by Indication, 2023-2030 (US$ Mn)
TABLE 375 Rest of Africa Controlled Substance Market, by Scheduling or Classification, 2017-2022 (US$ Mn)
TABLE 376 Rest of Africa Controlled Substance Market, by Scheduling or Classification, 2023-2030 (US$ Mn)
TABLE 377 Rest of Africa Controlled Substance Market, by Therapeutic Use, 2017-2022 (US$ Mn)
TABLE 378 Rest of Africa Controlled Substance Market, by Therapeutic Use, 2023-2030 (US$ Mn)
TABLE 379 Rest of Africa Controlled Substance Market, by Distribution Channel, 2017-2022 (US$ Mn)
TABLE 380 Rest of Africa Controlled Substance Market, by Distribution Channel, 2023-2030 (US$ Mn)
TABLE 381 Rest of Africa Controlled Substance Market, by Patient Demographics, 2017-2022 (US$ Mn)
TABLE 382 Rest of Africa Controlled Substance Market, by Patient Demographics, 2023-2030 (US$ Mn)
TABLE 383 Rest of Africa Controlled Substance Market, by Indication, 2017-2022 (US$ Mn)
TABLE 384 Rest of Africa Controlled Substance Market, by Indication, 2023-2030 (US$ Mn)